EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.4.39 | (5Z)-3-benzyl-5-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione | - |
Mus musculus | |
3.1.4.39 | 3-([4-[(Z)-(3-benzyl-2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-3-ethoxyphenoxy]methyl)benzoic acid | - |
Mus musculus | |
3.1.4.39 | 3-[(4-[(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]-3-methoxyphenoxy)methyl]benzoic acid | competitive inhibition, 35% residual ATX activity at 0.005 mM | Mus musculus | |
3.1.4.39 | 3-[(4-[(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]phenoxy)methyl]benzoic acid | competitive inhibition, 7% residual ATX activity at 0.005 mM | Mus musculus | |
3.1.4.39 | [3-[(4-[(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]phenoxy)methyl]phenyl]boronic acid | mixed-type inhibition, complete inhibition at 0.005 mM | Mus musculus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.1.4.39 | 0.094 | - |
lysophosphatidylcholine | - |
Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.4.39 | Mus musculus | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.4.39 | bis(4-nitrophenyl)phosphate + H2O | - |
Mus musculus | ? | - |
? | |
3.1.4.39 | lysophosphatidylcholine + H2O | - |
Mus musculus | lysophosphatidic acid + choline | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.4.39 | ATX | - |
Mus musculus |
3.1.4.39 | ATX/lysoPLD | - |
Mus musculus |
3.1.4.39 | autotaxin | - |
Mus musculus |
3.1.4.39 | NPP2 | - |
Mus musculus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.1.4.39 | 0.000028 | - |
in Tris-HCl buffer (pH 7.4) at 37°C | Mus musculus | [3-[(4-[(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]phenoxy)methyl]phenyl]boronic acid | |
3.1.4.39 | 0.00011 | - |
in Tris-HCl buffer (pH 7.4) at 37°C | Mus musculus | (5Z)-3-benzyl-5-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione | |
3.1.4.39 | 0.000161 | - |
in Tris-HCl buffer (pH 7.4) at 37°C | Mus musculus | 3-([4-[(Z)-(3-benzyl-2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-3-ethoxyphenoxy]methyl)benzoic acid | |
3.1.4.39 | 0.0017 | - |
in Tris-HCl buffer (pH 7.4) at 37°C | Mus musculus | 3-[(4-[(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]phenoxy)methyl]benzoic acid | |
3.1.4.39 | 0.0025 | - |
in Tris-HCl buffer (pH 7.4) at 37°C | Mus musculus | 3-[(4-[(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]-3-methoxyphenoxy)methyl]benzoic acid |